Objectives Patients with SLE take multiple medications. Within a large prospective longitudinal SLE cohort, we characterised ...
New bowel cancer test shows greater than 90% accuracy in high-risk patients - Experts hope to create a blood test to see ...
MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing solutions to advance the discovery, development and commercialization of next-generation cell ...
Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...